| Primary |
| Tuberculosis |
39.3% |
| Mycobacterium Avium Complex Infection |
27.0% |
| Lymph Node Tuberculosis |
4.5% |
| Meningitis Tuberculous |
4.5% |
| Pulmonary Tuberculosis |
4.5% |
| Mycobacterial Infection |
3.4% |
| Disseminated Tuberculosis |
2.2% |
| Eye Infection Bacterial |
2.2% |
| Lung Infection |
2.2% |
| Pulmonary Tuberculoma |
2.2% |
| Atypical Mycobacterial Infection |
1.1% |
| Bladder Cancer |
1.1% |
| Bone Tuberculosis |
1.1% |
| Breath Sounds Abnormal |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Hiv Infection |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
|
| Vision Blurred |
12.1% |
| Visual Impairment |
9.1% |
| Blindness |
6.1% |
| Headache |
6.1% |
| Optic Neuritis |
6.1% |
| Optic Neuropathy |
6.1% |
| Respiratory Failure |
6.1% |
| Toxicity To Various Agents |
6.1% |
| Visual Field Defect |
6.1% |
| Xanthopsia |
6.1% |
| Abdominal Pain |
3.0% |
| Convulsion |
3.0% |
| Drug Toxicity |
3.0% |
| Extradural Abscess |
3.0% |
| Hallucinations, Mixed |
3.0% |
| Malaise |
3.0% |
| Neuropathy Peripheral |
3.0% |
| Overdose |
3.0% |
| Pain |
3.0% |
| Paradoxical Drug Reaction |
3.0% |
|
| Secondary |
| Tuberculosis |
22.3% |
| Pulmonary Tuberculosis |
19.2% |
| Hiv Infection |
11.3% |
| Product Used For Unknown Indication |
8.8% |
| Drug Use For Unknown Indication |
8.5% |
| Mycobacterium Avium Complex Infection |
6.0% |
| Disseminated Tuberculosis |
5.5% |
| Atypical Mycobacterial Infection |
3.0% |
| Rheumatoid Arthritis |
2.9% |
| Prophylaxis |
2.4% |
| Lymph Node Tuberculosis |
1.6% |
| Meningitis Tuberculous |
1.1% |
| Pneumonia |
1.1% |
| Extrapulmonary Tuberculosis |
1.1% |
| Tuberculous Pleurisy |
1.0% |
| Antiretroviral Therapy |
1.0% |
| Cutaneous Tuberculosis |
0.9% |
| Hodgkin's Disease |
0.8% |
| Antibiotic Prophylaxis |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
|
| Vomiting |
13.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
11.1% |
| Liver Disorder |
5.5% |
| Paradoxical Drug Reaction |
5.1% |
| Renal Failure Chronic |
5.1% |
| Tuberculosis |
5.1% |
| Neuropathy Peripheral |
4.6% |
| Ascites |
4.1% |
| Drug Exposure During Pregnancy |
4.1% |
| Hepatotoxicity |
4.1% |
| Immune Reconstitution Syndrome |
4.1% |
| Pancytopenia |
4.1% |
| Deep Vein Thrombosis |
3.7% |
| Maternal Exposure During Pregnancy |
3.7% |
| Pyrexia |
3.7% |
| Renal Impairment |
3.7% |
| Toxic Epidermal Necrolysis |
3.7% |
| Visual Field Defect |
3.7% |
| Visual Impairment |
3.7% |
| Acute Hepatic Failure |
3.2% |
|
| Concomitant |
| Hiv Infection |
21.8% |
| Tuberculosis |
15.5% |
| Product Used For Unknown Indication |
15.4% |
| Pulmonary Tuberculosis |
9.0% |
| Drug Use For Unknown Indication |
8.8% |
| Mycobacterium Avium Complex Infection |
6.8% |
| Atypical Mycobacterial Infection |
5.5% |
| Prophylaxis |
2.9% |
| Hypertension |
1.7% |
| Mycobacterial Infection |
1.6% |
| Disseminated Tuberculosis |
1.5% |
| Antibiotic Prophylaxis |
1.3% |
| Bacterial Infection |
1.3% |
| Pneumocystis Jiroveci Pneumonia |
1.3% |
| Rheumatoid Arthritis |
1.2% |
| Pain |
1.1% |
| Immunosuppression |
1.0% |
| Antifungal Prophylaxis |
0.9% |
| Pneumonia |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
|
| Vomiting |
14.4% |
| Pyrexia |
10.5% |
| Weight Decreased |
7.2% |
| Immune Reconstitution Syndrome |
6.6% |
| Tuberculosis |
6.3% |
| Arrhythmia |
4.8% |
| Drug Interaction |
4.8% |
| Pneumonia |
4.2% |
| Renal Failure Acute |
4.2% |
| Thrombocytopenia |
4.2% |
| Pulmonary Tuberculosis |
3.9% |
| Death |
3.6% |
| Rash |
3.6% |
| Uveitis |
3.6% |
| Nausea |
3.3% |
| Renal Failure |
3.3% |
| Alanine Aminotransferase Increased |
3.0% |
| Liver Disorder |
3.0% |
| Diarrhoea |
2.7% |
| Drug Eruption |
2.7% |
|
| Interacting |
| Tuberculosis |
24.6% |
| Mycobacterium Avium Complex Infection |
14.4% |
| Infection |
6.8% |
| Stem Cell Transplant |
6.8% |
| Acute Myocardial Infarction |
5.9% |
| Angioplasty |
5.1% |
| Stent Placement |
5.1% |
| Thrombosis Prophylaxis |
5.1% |
| Breast Cancer Metastatic |
4.2% |
| Drug Use For Unknown Indication |
3.4% |
| Tuberculosis Gastrointestinal |
3.4% |
| Tuberculosis Liver |
3.4% |
| Aspergillosis |
1.7% |
| Bladder Cancer |
1.7% |
| Hypertension |
1.7% |
| Immunosuppression |
1.7% |
| Pulmonary Tuberculosis |
1.7% |
| Renal Transplant |
1.7% |
| Bovine Tuberculosis |
0.8% |
| Depression |
0.8% |
|
| Drug Interaction |
17.4% |
| Thrombosis In Device |
17.4% |
| Psychotic Disorder |
8.7% |
| Tachypnoea |
8.7% |
| Thrombosis |
8.7% |
| Anaemia |
4.3% |
| Blood Alkaline Phosphatase Increased |
4.3% |
| Drug Resistance |
4.3% |
| Loss Of Consciousness |
4.3% |
| Melaena |
4.3% |
| Muscular Weakness |
4.3% |
| Visual Impairment |
4.3% |
| Vomiting |
4.3% |
| Weight Decreased |
4.3% |
|
